Pacific Biosciences of California, Inc.
PACB
$1.37
-$0.01-0.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 79.50% | -6.24% | 9.37% | 90.16% | -18,070.27% |
| Total Depreciation and Amortization | -12.48% | 5.61% | -3.93% | -98.77% | 3,304.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -576.60% | -21.60% | -1.33% | 1.85% | 122.22% |
| Change in Net Operating Assets | -57.67% | 133.65% | 182.85% | -62.17% | -128.53% |
| Cash from Operations | -134.36% | -1.94% | 36.32% | 33.32% | -43.74% |
| Capital Expenditure | -253.43% | -1,101.16% | 115.64% | 60.40% | 14.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -141.27% | 42.91% | -27.16% | -44.59% | -22.11% |
| Cash from Investing | 37.77% | 37.71% | -25.24% | -44.11% | -22.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -100.00% | 103.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -206.25% | 318.27% | 140.64% | -230.51% | 113.87% |